A groundbreaking study will investigate Parkinson’s disease in unprecedented detail ... Researchers hope the findings will ...
Scientists have identified the melatonin MT1 receptor as a key regulator of REM sleep, crucial for memory, dreaming, and ...
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...
At first, Jonel suspected she was experiencing symptoms of Parkinson’s disease as she had seen her father’s experience ...
A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...
A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...